Femasys (NASDAQ:FEMY) CFO Dov Elefant Acquires 15,625 Shares

Femasys Inc. (NASDAQ:FEMY) CFO Dov Elefant purchased 15,625 shares of Femasys stock in a transaction dated Friday, August 7th. The shares were purchased at an average price of $3.20 per share, with a total value of $50,000.00. Following the completion of the transaction, the chief financial officer directly owned 15,625 shares in the company, valued at approximately $50,000. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link.

Femasys Trading Down 0.8%

Shares of FEMY stock opened at $2.35 on Wednesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.98 and a current ratio of 3.91. Femasys Inc. has a 52-week low of $2.29 and a 52-week high of $22.20. The company has a market capitalization of $7.10 million, a PE ratio of -0.44 and a beta of -2.08. The business’s fifty day moving average is $3.87 and its 200 day moving average is $7.49.

Analyst Upgrades and Downgrades

FEMY has been the topic of several recent analyst reports. Weiss Ratings raised Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 31st. Wall Street Zen raised Femasys to a “hold” rating in a report on Saturday, June 13th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Femasys currently has a consensus rating of “Hold” and a consensus price target of $80.00.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Geode Capital Management LLC lifted its holdings in shares of Femasys by 50.8% in the 4th quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock worth $224,000 after acquiring an additional 131,052 shares during the last quarter. Banco BTG Pactual S.A. bought a new position in shares of Femasys during the 4th quarter valued at $88,000. Jane Street Group LLC purchased a new position in Femasys in the 4th quarter worth $62,000. State Street Corp raised its position in Femasys by 43.5% in the 4th quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after purchasing an additional 24,500 shares during the period. Finally, Cetera Investment Advisers bought a new stake in Femasys in the fourth quarter worth $36,000. 65.27% of the stock is owned by hedge funds and other institutional investors.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.